REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of Name

7 Oct 2022 07:00

RNS Number : 0953C
Honeycomb Investment Trust PLC
07 October 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

THIS IS AN ANNOUNCEMENT AND NOT A PROSPECTUS OR EQUIVALENT DOCUMENT. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, ANY OFFER, INVITATION OR RECOMMENDATION TO PURCHASE, SELL OR SUBSCRIBE FOR ANY SECURITIES IN ANY JURISDICTION AND NEITHER THE ISSUE OF THE INFORMATION NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF OR BE RELIED UPON IN CONNECTION WITH, OR ACT AS AN INDUCEMENT TO ENTER INTO, ANY INVESTMENT ACTIVITY

 

FOR IMMEDIATE RELEASE

7 October 2022

Honeycomb Investment Trust plc ("Honeycomb")

Change of Name

Honeycomb announces, following the completion of the all share combination between Honeycomb and Pollen Street Capital Holdings Limited, that it has changed its name to Pollen Street plc. The change of name, which took effect yesterday, 6 October 2022, has been approved by the Board of Directors in accordance with Honeycomb's Articles of Association. Honeycomb's shares will trade under the new name on the London Stock Exchange from 8.00 a.m. London time on 10 October 2022. The Company's trading instrument display mnemonic ("TIDM") will also change from HONY to POLN with effect from 8.00 a.m. London time on 10 October 2022. The ISIN and SEDOL numbers will remain unchanged. As of today, the Company's website address has been amended to https://www.pollenstreetgroup.com/.

Enquiries:

Cenkos - Financial Adviser, Sponsor and Joint Broker to Honeycomb

Tunga Chigovanyika

Daniel BalabanoffJustin Zawoda Martin

+44 20 7397 8900

 

BofA Securities - Financial Adviser to Honeycomb Geoff Iles

Oliver Elias

Charles Pitt Ford

+44 20 7628 1000

Liberum - Joint Broker

Chris Clarke

+44 20 3100 2000

 

Barclays Bank PLC - Joint Broker Neal WestDion Di MiceliChris MaddersonStuart Muress+44 (0) 20 7623 2323

FGS Global - Communications Adviser

Chris Sibbald

+44 20 7251 3801

 

About Honeycomb

Honeycomb is a UK-listed closed ended investment trust dedicated to providing investors with access to asset backed lending opportunities, with potential to generate high income returns, together with strong capital preservation.

About Pollen Street

Pollen Street was founded in 2013 and is an independent, alternative investment management company dedicated to investing in the financial and business services sectors. Pollen Street has extensive experience investing in both credit and private equity strategies and has a strong and consistent track record of delivering top tier returns. A wholly owned subsidiary of Pollen Street serves as Honeycomb's investment manager.

Additional information

Merrill Lynch International ("BofA Securities"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the FCA and the PRA in the United Kingdom, is acting as financial adviser exclusively for Honeycomb and for no one else and will not be responsible to anyone other than Honeycomb for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement. Neither BofA Securities, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of BofA Securities in connection with this announcement, the Prospectus, or any statement contained herein or otherwise.

Cenkos Securities plc ("Cenkos"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as financial adviser and sponsor for Honeycomb and for no one else in connection with the Combination and Admission and will not be responsible to anyone other than Honeycomb for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement or any other arrangement referred to, or information contained in, the Prospectus. Neither Cenkos, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Cenkos in connection with this announcement, the Prospectus, or any statement contained herein or otherwise.

Liberum Capital Limited ("Liberum") is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for Honeycomb and no-one else in connection with the proposed Combination and will not be responsible to anyone other than the Honeycomb for providing the protections afforded to the clients of Liberum, as applicable, or for affording advice in relation to the contents of the announcement, the Prospectus, or any matters referred to therein. Nothing in this paragraph shall serve to exclude or limit any responsibilities Liberum may have under the Financial Services and Markets Act 2000 or the regulatory regime established thereunder.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CANFSDESMEESESS
Date   Source Headline
27th Jan 20206:26 pmRNSResult of Buy-Back and total voting rights
27th Jan 20204:08 pmRNSProposed Share Trade and Share Buy-Back
23rd Jan 20207:01 amRNSMonthly Update - December 2019
23rd Jan 20207:00 amRNSNet Asset Value(s)
20th Dec 20197:01 amRNSMonthly Update - November 2019
20th Dec 20197:00 amRNSNet Asset Value(s)
16th Dec 20191:51 pmRNSResult of General Meeting
29th Nov 20197:00 amRNSCircular and Notice of General Meeting
27th Nov 20197:01 amRNSMonthly Update - October 2019
27th Nov 20197:00 amRNSNet Asset Value(s)
19th Nov 20194:13 pmRNSHolding(s) in Company
8th Nov 20197:00 amRNSDividend Declaration
21st Oct 20197:01 amRNSMonthly Update - September 2019
21st Oct 20197:00 amRNSNet Asset Value(s)
30th Sep 20197:01 amRNSMonthly Update - August 2019
30th Sep 20197:00 amRNSNet Asset Value(s)
10th Sep 20197:00 amRNSHalf-year Report 2019
5th Sep 20193:02 pmRNSDividend Declaration
21st Aug 20197:01 amRNSMonthly Update - July 2019
21st Aug 20197:00 amRNSNet Asset Value(s)
12th Aug 20192:51 pmRNSPublication of Suppl.Prospcts
7th Aug 20195:13 pmRNSDirector/PDMR Shareholding
25th Jul 20197:01 amRNSMonthly Update - June 2019
25th Jul 20197:00 amRNSNet Asset Value(s)
25th Jun 201910:10 amRNSMonthly Update - 31 May 2019
25th Jun 201910:04 amRNSNet Asset Value(s)
14th Jun 20197:00 amRNSDirectorate Change
6th Jun 20195:33 pmRNSResult of AGM
21st May 20197:01 amRNSMonthly Update - 30 April 2019
21st May 20197:00 amRNSNet Asset Value(s)
3rd May 20192:46 pmRNSNotice of Annual Report & Director Resignation
29th Apr 20197:00 amRNSDividend Declaration
29th Apr 20197:00 amRNSAnnual Report and Audited Financial Statements
26th Apr 20197:01 amRNSMonthly Update - 31 March 2019
26th Apr 20197:00 amRNSNet Asset Value(s)
21st Mar 20197:01 amRNSMonthly Update - 28 February 2019
21st Mar 20197:00 amRNSNet Asset Value(s)
22nd Feb 20197:02 amRNSMonthly Update - 31 January 2019
22nd Feb 20197:01 amRNSDividend Declaration
22nd Feb 20197:00 amRNSNet Asset Value(s)
29th Jan 20197:01 amRNSFact Sheet December 2018
29th Jan 20197:00 amRNSNet Asset Value(s)
21st Dec 201812:49 pmRNSPlacing Programme: publication of prospectus
21st Dec 20187:01 amRNSMonthly Update - 30 November 2018
21st Dec 20187:00 amRNSNet Asset Value - 30 November 2018
22nd Nov 20187:01 amRNSMonthly Update - 31 October 2018
22nd Nov 20187:00 amRNSNet Asset Value - 31 October 2018
16th Nov 20187:00 amRNSDividend Declaration
23rd Oct 20187:01 amRNSMonthly Update - 30 September 2018
23rd Oct 20187:00 amRNSNet Asset Value - 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.